Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hasan

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|March 9, 2022
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Public Health|February 28, 2025
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Jeremy Samuel Faust, et al.
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
American Journal of Epidemiology|December 7, 2023
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study designHoussein H Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
Nature Medicine|November 3, 2021
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in QatarPatrick Tang, Mohammad R Hasan, Hiam Chemaitelly, et al.
The Lancet. Infectious Diseases|March 13, 2023
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort studyHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
The Lancet. Microbe|November 14, 2022
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Eclinicalmedicine|August 3, 2023
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studySuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
Vaccine|April 15, 2024
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradientLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|March 9, 2022
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in QatarLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Public Health|February 28, 2025
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Jeremy Samuel Faust, et al.
The New England Journal of Medicine|November 2, 2022
Covid-19 Vaccine Protection among Children and Adolescents in QatarHiam Chemaitelly, Sawsan AlMukdad, Houssein H Ayoub, et al.
American Journal of Epidemiology|December 7, 2023
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study designHoussein H Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
Nature Medicine|November 3, 2021
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in QatarPatrick Tang, Mohammad R Hasan, Hiam Chemaitelly, et al.
The Lancet. Infectious Diseases|March 13, 2023
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort studyHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
The Lancet. Microbe|November 14, 2022
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
Eclinicalmedicine|August 3, 2023
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studySuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
Vaccine|April 15, 2024
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradientLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Pageof 21